Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Transitional Cell

Explore clinical trials studying Carcinoma, Transitional Cell. Study availability and eligibility vary by location and protocol.

430 public trials 126 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Transitional Cell trial results

Recruiting

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

NCT05176483

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +48 more
Locations
  • Exelixis Clinical Site #67 Phoenix, Arizona, United States
  • Exelixis Clinical Site #1 Tucson, Arizona, United States
  • Exelixis Clinical Site #123 Palo Alto, California, United States
  • Exelixis Clinical Site #59 Santa Barbara, California, United States
View all 122 locations
View Trial Details
Recruiting

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

NCT06330064

Conditions
Adenocarcinoma, Adenocarcinoma Of Esophagus, Adnexal Diseases, +55 more
Locations
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • Los Angeles Cancer Network Los Angeles, California, United States
  • Pih Health Hematology Medical Oncology Whittier, California, United States
  • Orchard Healthcare Research Inc Skokie, Illinois, United States
View all 120 locations
View Trial Details
Recruiting

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

NCT06270706

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced or Metastatic Solid Tumor, +64 more
Locations
  • Yale University New Haven, Connecticut, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
  • South Texas Accelerated Research Therapeutics (START) Grand Rapids, Michigan, United States
  • NEXT Austin Austin, Texas, United States
View Trial Details
Recruiting

A Study of HLX18 vs. OPDIVO® in Multiple Resected Solid Tumors

NCT07518043

Conditions
Carcinoma, Carcinoma, Transitional Cell, Esophageal and/or Cardia Cancer, +14 more
Locations
  • Fujian Medical University Union Hospital Fuzhou, China
  • The First Affiliated Hospital Zhejiang University School Of Medicine Hangzhou, China
  • The First Affiliated Hospital of Henan University of Science & Technology Luoyang, China
  • The Second Hospital of Tianjin Medical University Tianjin, China
View Trial Details
Recruiting

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

NCT04879329

Conditions
Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +13 more
Locations
  • Banner Gateway Medical Center Gilbert, Arizona, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Kaiser Permanente Anaheim Kraemer Medical Offices Anaheim, California, United States
  • Foothill Cardioology Arcadia, California, United States
View all 221 locations
View Trial Details
Recruiting

An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC

NCT07720284

Conditions
Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +13 more
Locations
  • Research Site Hot Springs, Arkansas, United States
  • Research Site Little Rock, Arkansas, United States
  • Research Site Little Rock, Arkansas, United States
  • Research Site San Francisco, California, United States
View all 160 locations
View Trial Details

Related conditions